Rgenta Therapeutics LLC

Biotechnology company · Brookline, Massachusetts, United States

Rgenta Therapeutics LLC is a biotechnology company headquartered in Brookline, Massachusetts, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $400,034 in total, most recently in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Rgenta Therapeutics at a glance

Typebiotechnology company

HeadquartersBrookline, Massachusetts, United States

Employees (self-reported, 2020)4

What does Rgenta Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $400,034 in total (2020). NIH funding came from the National Institute of Neurological Disorders and Stroke.

Frequently asked questions about Rgenta Therapeutics

Where is Rgenta Therapeutics headquartered?

Rgenta Therapeutics LLC is headquartered in Brookline, Massachusetts, United States.

What does Rgenta Therapeutics do?

Rgenta Therapeutics LLC is a biotechnology company.

Similar companies

Crimson BioPharm Inc.Brookline, Massachusetts, United States
Day Zero Diagnostics, Inc.Brookline, Massachusetts, United States
Hypnalgesics, LLCBrookline, Massachusetts, United States
Navigation Sciences, Inc.Brookline, Massachusetts, United States
Hydroglyde Coatings, LLCBrookline, Massachusetts, United States
Adecto Pharmaceuticals, Inc.Brookline, Massachusetts, United States
Neurotargeting SystemsBrookline, Massachusetts, United States
Symbiotix Biotherapies, Inc.Brookline, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences